公开(公告)号：US12029752B2

公开(公告)日：2024-07-09

申请号：US16484002

申请日：2015-07-06

申请人： Koye Pharmaceuticals Private Limited

发明人： Ajay Nilawar

IPC分类号： A61K31/718 ,  A23L29/219 ,  A23L29/238 ,  A23L33/00 ,  A23L33/21 ,  A61K31/716 ,  A61K31/721 ,  A61K31/736 ,  A61K45/06 ,  A61P1/00 ,  A61P1/10 ,  A61P3/00 ,  A61P3/06 ,  A61P3/10

CPC分类号： A61K31/718 ,  A23L29/219 ,  A23L29/238 ,  A23L33/21 ,  A23L33/30 ,  A61K31/716 ,  A61K31/721 ,  A61K31/736 ,  A61K45/06 ,  A61P1/00 ,  A61P1/10 ,  A61P3/00 ,  A61P3/06 ,  A61P3/10

摘要： A water soluble dietary fibre composition and use thereof is disclosed. The composition comprises: (a) partially hydrolysed and re-polymerized starch, and (b) partially hydrolysed Guar gum.

公开(公告)号：US12023350B2

公开(公告)日：2024-07-02

申请号：US17706270

申请日：2022-03-28

申请人： Uplifting Results Labs, Inc.

发明人： Marc Washington ,  Ren-Hau Lai ,  Mengyu Zhao

IPC分类号： A61K31/718 ,  A23L33/115 ,  A23L33/185 ,  A23L33/22 ,  A61K9/00 ,  A61K38/00

CPC分类号： A61K31/718 ,  A23L33/115 ,  A23L33/185 ,  A23L33/22 ,  A61K9/0056 ,  A61K38/00 ,  A23V2002/00

摘要： A health benefiting daily nutrition includes protein, the protein having a protein weight. The health benefiting daily nutrition includes fiber, the fiber having a fiber weight. The fiber weight is more than 5 g. A ratio of [the protein weight]:[the fiber weight]=1:0.5-1.5.

公开(公告)号：US20240041944A1

公开(公告)日：2024-02-08

申请号：US18181504

申请日：2023-03-09

申请人： ISOThrive LLC

发明人： Lee Madsen, II ,  Jack Oswald ,  Sarah Stanley

IPC分类号： A61K35/66 ,  A61K31/702 ,  A61K31/732 ,  A61K31/733 ,  A61P1/00 ,  A61P3/00 ,  A61P35/00 ,  A61P5/00 ,  C12Q1/689 ,  A61K35/744 ,  A61K31/717 ,  A61K31/715 ,  A61K31/718 ,  A61K31/736 ,  C12Q1/04 ,  C12Q1/68

CPC分类号： A61K35/66 ,  A61K31/702 ,  A61K31/732 ,  A61K31/733 ,  A61P1/00 ,  A61P3/00 ,  A61P35/00 ,  A61P5/00 ,  C12Q1/689 ,  A61K35/744 ,  A61K31/717 ,  A61K31/715 ,  A61K31/718 ,  A61K31/736 ,  C12Q1/04 ,  C12Q1/68

摘要： Methods are described herein for identifying and providing prebiotic compositions that are optimized for the health needs of individuals.

公开(公告)号：US11857553B2

公开(公告)日：2024-01-02

申请号：US16366936

申请日：2019-03-27

申请人： NUTRITION 21, LLC

发明人： James R. Komorowski

IPC分类号： A61K31/555 ,  A61K31/718 ,  A61K33/24 ,  A23L33/165 ,  A23L33/17 ,  A23L33/125 ,  A23L33/16 ,  A61K9/08 ,  A61K9/14 ,  A61K31/198 ,  A61K31/732 ,  A61K36/899 ,  A61K38/01 ,  A61K45/06

CPC分类号： A61K31/555 ,  A23L33/125 ,  A23L33/16 ,  A23L33/165 ,  A23L33/17 ,  A61K9/08 ,  A61K9/14 ,  A61K31/198 ,  A61K31/718 ,  A61K31/732 ,  A61K33/24 ,  A61K36/899 ,  A61K38/018 ,  A61K45/06 ,  A23V2002/00 ,  A61K31/718 ,  A61K2300/00 ,  A61K31/555 ,  A61K2300/00

摘要： Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle protein breakdown, and fat mass.

公开(公告)号：US20180333429A1

公开(公告)日：2018-11-22

申请号：US15596372

申请日：2017-05-16

申请人： Medical Symbiosis Pty Ltd

发明人： David Reiner

IPC分类号： A61K31/718 ,  A61K9/00 ,  A23L2/60

CPC分类号： A61K31/718 ,  A23L2/60 ,  A23V2002/00 ,  A61K9/0053 ,  A61K9/0095

摘要： The present invention relates to a fasting formulation and a method of use that assists a patient during a fasting period and to reduce side effects of the fasting. Furthermore, the invention promotes better recovery from fasting. The formulation contains maltodextrin and is devoid of simple sugars. The invention further relates to the use of the formulation as a pre-operative for preparing for surgery and anaesthesia using the formulation.

公开(公告)号：US10010563B2

公开(公告)日：2018-07-03

申请号：US14435362

申请日：2012-11-27

申请人： TERUMO KABUSHIKI KAISHA

发明人： Hirokazu Usami ,  Yoshihiko Koyama ,  Hiroshi Nishitani ,  Tsuyoshi Ariizumi

IPC分类号： A61M1/00 ,  A61K33/14 ,  A61K31/718 ,  A61M1/28 ,  A61J1/10 ,  A61J1/20

CPC分类号： A61K33/14 ,  A61J1/10 ,  A61J1/202 ,  A61J1/2093 ,  A61K31/718 ,  A61M1/287 ,  A61K2300/00

摘要： The present invention is a sterile peritoneal dialysis fluid, including an acidic first liquid containing 60.0 to 94.0 g/L of icodextrin and 0 to 2.34 g/L of sodium chloride, and an alkaline second liquid containing an alkaline pH regulator, in which the first liquid after sterilization has a pH of 5.0 to 5.5, the second liquid after sterilization has a pH of 6.5 to 7.5, and a mixture of the first liquid and the second liquid after sterilization has a pH of 6.0 to 7.5. The present invention can provide a peritoneal dialysis fluid containing icodextrin, in which the stability of icodextrin during the heat sterilization and the subsequent storage can be improved to the maximum, and the pH of the peritoneal dialysis fluid is close to the physiological range.

公开(公告)号：US09861654B2

公开(公告)日：2018-01-09

申请号：US14426253

申请日：2013-09-06

申请人： MCPHARMA BIOTECH INC.

发明人： Derek McLaren ,  Earl McClaren

IPC分类号： A23K1/18 ,  A61K31/718 ,  A61K36/81 ,  A61K9/20 ,  A23K40/10 ,  A23K40/30 ,  A23K10/35 ,  A23K20/163 ,  A23K50/10 ,  A23K50/30 ,  A23K50/60

CPC分类号： A61K31/718 ,  A23K10/35 ,  A23K20/163 ,  A23K40/10 ,  A23K40/30 ,  A23K50/10 ,  A23K50/30 ,  A23K50/60 ,  A23V2002/00 ,  A61K9/2027 ,  A61K9/2059 ,  A61K36/81 ,  A23V2200/32 ,  A23V2250/5118

摘要： Low levels of resistant potato starch, for example, 0.5-1.0% of total diet, have a beneficial effect on post-weaning diarrhea, infectious diarrhea and gastrointestinal stresses associated with weaning. Also described are capsules and tablets of resistant potato starch, and methods for making said capsules and tablets.

公开(公告)号：US20170274078A1

公开(公告)日：2017-09-28

申请号：US15505039

申请日：2015-08-27

申请人： The General Hospital Corporation

发明人： Lilit Garibyan ,  Richard Rox Anderson ,  William A. Farinelli ,  Emilia Javorsky

IPC分类号： A61K45/06 ,  A61K31/765 ,  A61K31/7004 ,  A61K31/718 ,  A61K31/047 ,  A61K31/137

CPC分类号： A61K45/06 ,  A61K9/0019 ,  A61K9/0024 ,  A61K31/045 ,  A61K31/047 ,  A61K31/137 ,  A61K31/167 ,  A61K31/245 ,  A61K31/445 ,  A61K31/7004 ,  A61K31/718 ,  A61K31/765 ,  A61K33/00 ,  A61K47/02 ,  A61K47/10 ,  A61K47/18 ,  A61K47/26 ,  A61K47/28 ,  A61K2300/00

摘要： Described herein are compositions comprising, and methods for using, biocompatible cold slurries and methods of administering the same to provide reversible inhibition of peripheral nerves in a subject in need thereof.

公开(公告)号：US20170239267A1

公开(公告)日：2017-08-24

申请号：US15427471

申请日：2017-02-08

申请人： Nutrition 21, LLC

发明人： James R. Komorowski

IPC分类号： A61K31/555 ,  A61K38/01 ,  A61K31/198 ,  A23L33/125 ,  A61K9/14 ,  A61K9/08 ,  A61K36/899 ,  A23L33/16 ,  A61K45/06 ,  A61K31/732

CPC分类号： A61K31/555 ,  A23L33/125 ,  A23L33/16 ,  A23L33/165 ,  A23L33/17 ,  A23V2002/00 ,  A61K9/08 ,  A61K9/14 ,  A61K31/198 ,  A61K31/718 ,  A61K31/732 ,  A61K33/24 ,  A61K36/899 ,  A61K38/018 ,  A61K45/06 ,  A61K2300/00

摘要： Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle protein breakdown, and fat mass.

公开(公告)号：US20170042950A1

公开(公告)日：2017-02-16

申请号：US15233204

申请日：2016-08-10

申请人： SHAKLEE CORPORATION

发明人： Francis C. Lau ,  Bruce P. Daggy ,  Emanuel P. Fakoukakis

IPC分类号： A61K35/744 ,  A23L33/22 ,  A23L33/21 ,  A23L33/135

CPC分类号： A61K35/744 ,  A23K10/18 ,  A23K20/163 ,  A23L33/135 ,  A23L33/21 ,  A23L33/22 ,  A23V2002/00 ,  A23V2200/328 ,  A23V2250/284 ,  A61K31/702 ,  A61K31/718 ,  A61K31/732 ,  A61K31/733 ,  A61K31/736 ,  A61K35/742 ,  A61K36/48 ,  A61K2035/11 ,  A23V2200/32 ,  A23V2200/3202 ,  A23V2200/3204 ,  A23V2250/5116 ,  A61K2300/00

摘要： Described herein is a composition comprising a mixture of a probiotic composition and a prebiotic composition, wherein the probiotic composition comprises the bacterium Bacillus coagulans and wherein the prebiotic composition comprises a plant-based fiber, a resistant starch and a short-chain oligosaccharide. Uses of the compositions described herein for maintaining or improving gastrointestinal health is also contemplated.

摘要翻译： 本文描述的是包含益生菌组合物和益生元组合物的混合物的组合物，其中益生菌组合物包含细菌凝结芽孢杆菌，并且其中益生元组合物包含植物纤维，抗性淀粉和短链寡糖。 还考虑了本文所述的用于维持或改善胃肠健康的组合物的用途。